Cargando…
601. Characterizing Modifiable Risk Factors for Liposomal Amphotericin B (L-AMB) Nephrotoxicity
BACKGROUND: Liposomal amphotericin B (L-AMB) is a broad spectrum anti-fungal utilized in the treatment of serious fungal infections. Despite its liposomal formulation aimed at reducing toxicity, it is still associated with relatively high rates of nephrotoxicity. Few studies have attempted to assess...
Autores principales: | Bialick, Kate, Leu, Teresa, Liu, Catherine, Tverdek, Frank P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752136/ http://dx.doi.org/10.1093/ofid/ofac492.653 |
Ejemplares similares
-
2109. Liposomal Amphotericin B-associated Nephrotoxicity in Obese and Non-obese Patients
por: Tritle, Brandon, et al.
Publicado: (2019) -
370. Efficacy of Cochleated Amphotericin B (C-AMB) in Mouse Models of Oropharyngeal and Vulvovaginal Candidiasis
por: Desai, Jigar V, et al.
Publicado: (2018) -
Renal Recovery following Liposomal Amphotericin B-Induced Nephrotoxicity
por: Personett, Heather A., et al.
Publicado: (2019) -
Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study
por: Azoulay, Elie, et al.
Publicado: (2017) -
Characterization of a Polyethylene Glycol-Amphotericin B Conjugate Loaded with Free AMB for Improved Antifungal Efficacy
por: Tan, Tessa Rui Min, et al.
Publicado: (2016)